Literature DB >> 15753379

Iterative microarray and RNA interference-based interrogation of the SRC-induced invasive phenotype.

Rosalyn B Irby1, Renae L Malek, Greg Bloom, Jennifer Tsai, Noah Letwin, Bryan C Frank, Kathleen Verratti, Timothy J Yeatman, Norman H Lee.   

Abstract

Src kinase has long been recognized as a factor in the progression of colorectal cancer and seems to play a specific role in the development of the metastatic phenotype. In spite of numerous studies conducted to elucidate the exact role of Src in cancer progression, downstream targets of Src remain poorly understood. Gene expression profiling has permitted the identification of large sets of genes that may be functionally interrelated but it is often unclear as to which molecular pathways they belong. Here we have developed an iterative approach to experimentally reconstruct a network of gene activity regulated by Src and contributing to the invasive phenotype. Our strategy uses a combination of phenotypic anchoring of gene expression profiles and loss-of-function screening by way of RNA-mediated interference. Using a panel of human colon cancer cell lines exhibiting differential Src-specific activity and invasivity, we identify the first two levels of gene transcription responsible for the invasive phenotype, where first-tier genes are controlled by Src activity and the second-tier genes are under the influence of the first tier. Specifically, perturbation of first-tier gene activity by either pharmacologic inhibition of Src or RNA-mediated interference-directed knockdown leads to a loss of invasivity and decline of second-tier gene activity. The targeting of first-tier genes may be bypassed altogether because knockdown of second-tier genes led to a similar loss of invasive potential. In this manner, numerous members of a "transcriptional cascade" pathway for metastatic activity have been identified and functionally validated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753379     DOI: 10.1158/0008-5472.CAN-04-3609

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Pgrmc1 (progesterone receptor membrane component 1) associates with epidermal growth factor receptor and regulates erlotinib sensitivity.

Authors:  Ikhlas S Ahmed; Hannah J Rohe; Katherine E Twist; Rolf J Craven
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Secretome signature of invasive glioblastoma multiforme.

Authors:  Catherine A Formolo; Russell Williams; Heather Gordish-Dressman; Tobey J MacDonald; Norman H Lee; Yetrib Hathout
Journal:  J Proteome Res       Date:  2011-05-31       Impact factor: 4.466

3.  Progesterone receptor membrane component 1 promotes survival of human breast cancer cells and the growth of xenograft tumors.

Authors:  Nicole C Clark; Anne M Friel; Cindy A Pru; Ling Zhang; Toshi Shioda; Bo R Rueda; John J Peluso; James K Pru
Journal:  Cancer Biol Ther       Date:  2016-01-19       Impact factor: 4.742

4.  Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion.

Authors:  Carrie D House; Charles J Vaske; Arnold M Schwartz; Vincent Obias; Bryan Frank; Truong Luu; Narine Sarvazyan; Rosalyn Irby; Robert L Strausberg; Tim G Hales; Joshua M Stuart; Norman H Lee
Journal:  Cancer Res       Date:  2010-07-22       Impact factor: 12.701

Review 5.  PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.

Authors:  Hannah J Rohe; Ikhlas S Ahmed; Katherine E Twist; Rolf J Craven
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

6.  Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NF kappaB and microRNA network.

Authors:  Bi-Dar Wang; Christina Leah B Kline; Danielle M Pastor; Thomas L Olson; Bryan Frank; Truong Luu; Arun K Sharma; Gavin Robertson; Matthew T Weirauch; Steven R Patierno; Joshua M Stuart; Rosalyn B Irby; Norman H Lee
Journal:  Mol Cancer       Date:  2010-04-30       Impact factor: 27.401

7.  Synovial expression of Th17-related and cancer-associated genes is regulated by the arthritis severity locus Cia10.

Authors:  E Jenkins; M Brenner; T Laragione; P S Gulko
Journal:  Genes Immun       Date:  2011-11-03       Impact factor: 2.676

8.  Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma.

Authors:  A P Algazi; J S Weber; S C Andrews; P Urbas; P N Munster; R C DeConti; J Hwang; V K Sondak; J L Messina; T McCalmont; A I Daud
Journal:  Br J Cancer       Date:  2011-11-29       Impact factor: 7.640

9.  Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.

Authors:  Hiroki Honda; Masaaki Takamura; Satoshi Yamagiwa; Takuya Genda; Ryoko Horigome; Naruhiro Kimura; Toru Setsu; Kentaro Tominaga; Hiroteru Kamimura; Yasunobu Matsuda; Toshifumi Wakai; Yutaka Aoyagi; Shuji Terai
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

10.  A factor graph nested effects model to identify networks from genetic perturbations.

Authors:  Charles J Vaske; Carrie House; Truong Luu; Bryan Frank; Chen-Hsiang Yeang; Norman H Lee; Joshua M Stuart
Journal:  PLoS Comput Biol       Date:  2009-01-30       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.